( More than 800 poor Americans are yet to...)800 People On US Waiting List for AIDS Drugs,Health

More than 800 poor Americans are yet to receive AIDS medications from government-funded programs, which are most often the last resort to those who cannot afford to buy costly treatments, //according to an annual survey in the US.

The report added that several US states were also forced to cut down on the medications that were allocated to AIDS Drug Assistance Programs, or ADAPs, due to a shortage of funds. "The need for HIV-related medications continues to outstrip their availability," said the report by the Kaiser Family Foundation, a nonprofit health research organization, and the National Association of State and Territorial AIDS Directors. The report added that according to the latest available figures for the month of February Alaska, Idaho, Montana, Nebraska, Arkansas, Indiana, Kentucky, West Virginia and Alabama had a waiting list of about 791 people who could not afford the costly drugs. "ADAPs will continue to have to make difficult trade-off decisions between serving more people with less services or serving less people with more services," the report said. It called on the Congress to make some changes to the laws so that the waiting periods are considerably cut down. The cost of the drugs per person worked out to be $1,064 in June 2005, when ADAPs spent $102.6 million to provide the anti-retroviral drugs to 96,404 patients.
'"/>




Page: 1
Related medicine news :

1. Bad News for Short People
2. New hope on the Horizon for People Wishing to Quit Smoking
3. Prescription Drug - Helps People Stop Smoking
4. More People Seeking Treatment for Depression
5. Pain Common in People with MS
6. People with skin cancer at higher risk for other types
7. Laser Therapy Found To Help People Quit Smoking
8. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
9. New Treatment For People Allergic To Cats
10. People who fight wars may be at high risk of cardiovascular disease
11. People suffering from Alzheimer’s: can they take decisions about their treatment